Home
NEO
NEO News

Latest NeoGenomics Inc. (NEO) News on November 9, 2025

NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors

Business Wire

9 days ago

NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors

NeoGenomics (NEO): Losses Widen, Profitability Still Elusive as Revenue Trails Market Growth

Simply Wall St.

10 days ago

NeoGenomics (NEO): Losses Widen, Profitability Still Elusive as Revenue Trails Market Growth

NeoGenomics (NEO) Valuation: Is the Recent Rebound a True Turning Point?

Simply Wall St.

10 days ago

NeoGenomics (NEO) Valuation: Is the Recent Rebound a True Turning Point?

NEO Q3 Deep Dive: Clinical Volume Gains and New Product Launches Shape Outlook

StockStory

11 days ago

NEO Q3 Deep Dive: Clinical Volume Gains and New Product Launches Shape Outlook

NeoGenomics (NEO) Q3 2025 Earnings Call Transcript

Motley Fool

11 days ago

NeoGenomics (NEO) Q3 2025 Earnings Call Transcript

Why NeoGenomics (NEO) Stock Is Trading Up Today

StockStory

11 days ago

Why NeoGenomics (NEO) Stock Is Trading Up Today

NeoGenomics (NEO) Surpasses Q3 Earnings and Revenue Estimates

Zacks

12 days ago

NeoGenomics (NEO) Surpasses Q3 Earnings and Revenue Estimates

MT Newswires

12 days ago

NeoGenomics Q3 Adjusted Earnings Fall, Revenue Rises; Annual Outlook Reaffirmed -- Shares Up Pre-Bell

NeoGenomics (NEO) Moves 6.3% Higher: Will This Strength Last?

Zacks

24 days ago

NeoGenomics (NEO) Moves 6.3% Higher: Will This Strength Last?

NeoGenomics (NEO): Assessing Valuation Following Recent Share Price Momentum

Simply Wall St.

24 days ago

NeoGenomics (NEO): Assessing Valuation Following Recent Share Price Momentum

agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know

StockStory

a month ago

agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know

Here’s Alger Weatherbie Specialized Growth Fund’s Comment on NeoGenomics (NEO)

Insider Monkey

2 months ago

Here’s Alger Weatherbie Specialized Growth Fund’s Comment on NeoGenomics (NEO)

1 Safe-and-Steady Stock Worth Your Attention and 2 We Ignore

StockStory

2 months ago

1 Safe-and-Steady Stock Worth Your Attention and 2 We Ignore

Why NeoGenomics (NEO) Shares Are Falling Today

StockStory

2 months ago

Why NeoGenomics (NEO) Shares Are Falling Today

Argus Research

4 months ago

NEO: What does Argus have to say about NEO?

5 Insightful Analyst Questions From NeoGenomics’s Q1 Earnings Call

StockStory

4 months ago

5 Insightful Analyst Questions From NeoGenomics’s Q1 Earnings Call

NeoGenomics Appoints Dr. Marjorie Green to Board of Directors

Business Wire

5 months ago

NeoGenomics Appoints Dr. Marjorie Green to Board of Directors

3 Cash-Burning Stocks Facing Headwinds

StockStory

5 months ago

3 Cash-Burning Stocks Facing Headwinds

3 Unprofitable Stocks in Hot Water

StockStory

5 months ago

3 Unprofitable Stocks in Hot Water

Argus Research

5 months ago

NEO: What does Argus have to say about NEO?

Testing & Diagnostics Services Stocks Q1 Teardown: Quest (NYSE:DGX) Vs The Rest

StockStory

5 months ago

Testing & Diagnostics Services Stocks Q1 Teardown: Quest (NYSE:DGX) Vs The Rest

3 Volatile Stocks in Hot Water

StockStory

5 months ago

3 Volatile Stocks in Hot Water

NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025

Business Wire

5 months ago

NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025

Firing on All Cylinders: Guardant Health (NASDAQ:GH) Q1 Earnings Lead the Way

StockStory

5 months ago

Firing on All Cylinders: Guardant Health (NASDAQ:GH) Q1 Earnings Lead the Way

NeoGenomics introduces c-MET companion diagnostic for NSCLC

Medical Device Network

6 months ago

NeoGenomics introduces c-MET companion diagnostic for NSCLC

NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer

Business Wire

6 months ago

NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer

Envista, NeoGenomics, Acadia Healthcare, Astrana Health, and Hims & Hers Health Stocks Trade Down, What You Need To Know

StockStory

6 months ago

Envista, NeoGenomics, Acadia Healthcare, Astrana Health, and Hims & Hers Health Stocks Trade Down, What You Need To Know

NeoGenomics to Participate in Upcoming June Investor Conferences

Business Wire

6 months ago

NeoGenomics to Participate in Upcoming June Investor Conferences

3 Healthcare Stocks with Mounting Challenges

StockStory

6 months ago

3 Healthcare Stocks with Mounting Challenges

MT Newswires

6 months ago

Guggenheim Initiates Coverage on NeoGenomics With Neutral Rating

3 Russell 2000 Stocks in the Doghouse

StockStory

6 months ago

3 Russell 2000 Stocks in the Doghouse

Argus Research

6 months ago

NEO: Rating increased to a HOLD

NEO Q1 Earnings Call: Sales Growth, Pharma Headwinds, and Pathline Integration Shape Outlook

StockStory

6 months ago

NEO Q1 Earnings Call: Sales Growth, Pharma Headwinds, and Pathline Integration Shape Outlook

Chief Financial Officer of NeoGenomics Jeffrey Sherman Buys 14% More Shares

Simply Wall St.

6 months ago

Chief Financial Officer of NeoGenomics Jeffrey Sherman Buys 14% More Shares

Argus Research

6 months ago

NEO: Raising target price to $6.00

NeoGenomics First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

6 months ago

NeoGenomics First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Small-Cap Stocks Walking a Fine Line

StockStory

6 months ago

3 Small-Cap Stocks Walking a Fine Line

MT Newswires

6 months ago

NeoGenomics Repays $201.3 Million Convertible Senior Notes

NeoGenomics price target lowered to $10 from $17 at Morgan Stanley

TipRanks

6 months ago

NeoGenomics price target lowered to $10 from $17 at Morgan Stanley

NeoGenomics Pays Off 1.25% Convertible Senior Notes

Business Wire

6 months ago

NeoGenomics Pays Off 1.25% Convertible Senior Notes

MT Newswires

6 months ago

Leerink Partners Downgrades NeoGenomics to Market Perform From Outperform, Lowers Price Target to $9 From $25

GuruFocus.com

6 months ago

NeoGenomics Inc (NEO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Why NeoGenomics (NEO) Stock Is Nosediving

StockStory

6 months ago

Why NeoGenomics (NEO) Stock Is Nosediving

MT Newswires

6 months ago

Needham Cuts NeoGenomics' Price Target to $8.50 From $18, Maintains Buy Rating

MT Newswires

6 months ago

NeoGenomics Expands Cancer Test Offerings With Ultima Genomics Collaboration

MT Newswires

6 months ago

NeoGenomics Posts Q1 Breakeven Adjusted Earnings as Revenue Rises; 2025 Guidance Updated

NeoGenomics (NEO) Reports Break-Even Earnings for Q1

Zacks

6 months ago

NeoGenomics (NEO) Reports Break-Even Earnings for Q1

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform

PR Newswire

6 months ago

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform

NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops

StockStory

6 months ago

NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops

Associated Press Finance

6 months ago

NeoGenomics: Q1 Earnings Snapshot

NeoGenomics Reports First Quarter 2025 Results

Business Wire

6 months ago

NeoGenomics Reports First Quarter 2025 Results

NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For

StockStory

6 months ago

NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for

Zacks

7 months ago

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for

NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

7 months ago

NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting

Business Wire

7 months ago

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting

Argus Research

7 months ago

NEO: Rating decreased to a SELL

MT Newswires

7 months ago

BofA Securities Adjusts Price Target on NeoGenomics to $12 From $16, Maintains Neutral Rating

Argus Research

7 months ago

NEO: Lowering target price to $9.00

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025

Business Wire

7 months ago

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025

MT Newswires

7 months ago

NeoGenomics Closes Pathline Acquisition

NeoGenomics Completes Acquisition of Pathline

Business Wire

7 months ago

NeoGenomics Completes Acquisition of Pathline

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

StockStory

7 months ago

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

Argus Research

7 months ago

NEO: What does Argus have to say about NEO?

MT Newswires

7 months ago

NeoGenomics Appoints Tony Zook Chief Executive

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics

Business Wire

7 months ago

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics

A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack

StockStory

7 months ago

A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack

Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses

StockStory

7 months ago

Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses

3 Reasons to Sell NEO and 1 Stock to Buy Instead

StockStory

8 months ago

3 Reasons to Sell NEO and 1 Stock to Buy Instead

MT Newswires

8 months ago

NeoGenomics Names Warren Stone President, COO

NeoGenomics Appoints Warren Stone as President & Chief Operating Officer

Business Wire

8 months ago

NeoGenomics Appoints Warren Stone as President & Chief Operating Officer

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)

StockStory

8 months ago

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)

3 Small-Cap Stocks in Hot Water

StockStory

8 months ago

3 Small-Cap Stocks in Hot Water

MT Newswires

8 months ago

NeoGenomics Acquires Pathline

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

Business Wire

8 months ago

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

Argus Research

8 months ago

NEO: Lowering target price to $10.00

3 Healthcare Stocks Skating on Thin Ice

StockStory

8 months ago

3 Healthcare Stocks Skating on Thin Ice

Argus Research

8 months ago

NEO: Lowering target price to $11.00

NeoGenomics to Participate in Upcoming Investor Conferences

Business Wire

9 months ago

NeoGenomics to Participate in Upcoming Investor Conferences

NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

9 months ago

NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations

GuruFocus.com

9 months ago

NeoGenomics Inc (NEO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Thomson Reuters StreetEvents

9 months ago

Q4 2024 Neogenomics Inc Earnings Call

Argus Research

9 months ago

NEO: Lowering target price to $13.00

Why NeoGenomics (NEO) Shares Are Trading Lower Today

StockStory

9 months ago

Why NeoGenomics (NEO) Shares Are Trading Lower Today

NeoGenomics (NEO) Tops Q4 Earnings Estimates

Zacks

9 months ago

NeoGenomics (NEO) Tops Q4 Earnings Estimates

MT Newswires

9 months ago

NeoGenomics Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued -- Shares Drop Pre-Bell

Associated Press Finance

9 months ago

NeoGenomics: Q4 Earnings Snapshot

NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets

StockStory

9 months ago

NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results

Business Wire

9 months ago

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results

NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect

StockStory

9 months ago

NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect

Thomson Reuters StreetEvents

9 months ago

Q4 2024 Adaptive Biotechnologies Corp Earnings Call

Argus Research

9 months ago

NEO: Lowering target price to $15.00

MT Newswires

9 months ago

Pacific Biosciences of California Appoints NeoGenomics CEO to Board of Directors

PacBio Announces Appointment of Chris Smith to Board of Directors

GlobeNewswire

9 months ago

PacBio Announces Appointment of Chris Smith to Board of Directors

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025

Business Wire

9 months ago

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025

Argus Research

9 months ago

NEO: Raising target price to $16.00

Strong week for NeoGenomics (NASDAQ:NEO) shareholders doesn't alleviate pain of five-year loss

Simply Wall St.

9 months ago

Strong week for NeoGenomics (NASDAQ:NEO) shareholders doesn't alleviate pain of five-year loss

Argus Research

10 months ago

NEO: Raising target price to $15.00

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance

Investor's Business Daily

10 months ago

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance

MT Newswires

10 months ago

NeoGenomics Provides 2025 Revenue Outlook

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

Business Wire

10 months ago

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

Share on Social Networks: